Reach Us +44 1704335730


Evaluating the effect of chewing Aspocid versus its soluble form used for heart disease children on the microhardness of primary teeth Enamel. (In Vitro-study)

Aspocid 75 mg chewing tablets (pH = 3) is the usual drug used in children with heart disease, this acidic medicine is available in Egyptian markets and accessible by the public. This may lead to increase their susceptibility to dental erosion.The aim of this study was to compare the effect of chewing aspocid on the micro hardness of primary teeth and comparing it with that of its soluble form. total number of thirty six exfoliated primary teeth were randomly assigned to two groups after measuring micro hardness at base line: group (A) Exposed to chewing aspocid tablets under vibration to mimic the chewing process, group (B) Exposed to 100 ml aspocid solution. All teeth were prepared for micro hardness test after acidic treatment. Results: Microhardness decreased in both groups. However group (A) showed higher reduction in its micro hardness values than group (B).

Author(s): Gehan Gaber Allam

Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Flyer image
Abstracted/Indexed in
  • Index Copernicus
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Cosmos IF
  • Directory of Research Journal Indexing (DRJI)
  • Secret Search Engine Labs